We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Glenn Levine

Glenn N Levine MD, FAHA, FACC

Professor of Medicine, Baylor College of Medicine. Director, Cardiac Care Unit, Michael E. DeBakey VA Medical Center; Chair, ACC/AHA Task Force on Clinical Practice Guidelines

Recent Contributions to PracticeUpdate:

  1. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
  2. Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery
  3. Risk Associated With Surgery Within 12 Months After Coronary DES Implantation
  4. Early Cessation of Adenosine Receptor Inhibitors Increases Risk for MACE

Most Read This Week

Recently Updated